European Union · medicines access
Prescription costs and reimbursement across the EU
Prepare for upfront pharmacy costs and ask your home insurer about the specific medicine, documents and claim route.
Start with your insurance country
Reimbursement depends on the rules of the insurer responsible for your coverage and the circumstances of the purchase. Nationality, the seller’s address and the delivery destination do not by themselves identify the paying insurer. Tell the insurer exactly which medicine, prescription and purchase route you intend to use.
A foreign prescription often means paying first
Your Europe explains that when using a prescription from one country in another, you may need to pay the full medicine price and seek reimbursement afterwards if eligible. The amount and conditions follow the applicable home-country rules. An EU prescription’s recognition is therefore separate from how the purchase is funded.
EHIC applies to a different situation
Your Europe distinguishes necessary care during a temporary stay where a locally issued prescription and EHIC arrangements may allow the same terms as locally insured patients. When presenting a cross-border prescription, you will generally need to pay upfront and ask the home insurer about reimbursement. Do not treat EHIC as a general online checkout entitlement.
Ask about the exact purchase before committing
Identify the product’s common name, strength, form and quantity, the prescription country and date, dispensing country, seller and whether collection or shipment is intended. Ask whether this purchase is eligible, how any payable amount is calculated, whether approval is required for your circumstances, and which supporting documents are needed. Record the insurer’s response rather than relying on a seller’s estimate.
- Which insurer or body is responsible for the claim?
- Is the exact medicine and purchase route covered?
- What amount, limit or patient contribution applies?
- Is any approval needed for these circumstances?
- Which prescription, receipt and payment documents are required?
- How and when should the claim be submitted?
Keep the dispensing record
Request an itemised receipt identifying the medicines and charge. Keep the prescription information, proof of payment and any insurer instructions. Ask the insurer about translation or additional evidence if the receipt language differs from its usual claim language. These are preparation steps; the insurer’s actual documentation rules govern the claim.
National coverage examples have a limited scope
Luxembourg’s CNS explains its positive-list and exceptional-authorisation medicine coverage arrangements. That national guidance does not establish every cross-border purchase entitlement. For Finnish prescriptions dispensed abroad, Kanta advises patients about applying to Kela for medicine-expense reimbursement; eligibility still needs to be checked for the individual insured person.
Contact points help you find the right rules
National Contact Points provide information on cross-border healthcare and can help route questions. Use the official directory or your country’s contact-point website. An NCP directory entry confirms contact routing; it is not evidence that a specific medicine or internet order will be reimbursed.
If a claim or payment request is refused
Ask for the reason and the applicable rule, then ask what clarification or review process is available. Keep the correspondence with your purchase documents. Resolve treatment questions with your prescriber or pharmacist, and coverage questions with the insurer; a substitute product may change both dispensing and coverage eligibility.
EU approval does not automatically mean national reimbursement
EU marketing authorisation and national medicine funding are separate steps. A medicine can receive approval for use across the European Union while pricing, reimbursement and routine patient access are still being assessed within individual member states.
A current example is Rasonque (daraxonrasib), which has been recommended for EU authorisation for metastatic pancreatic cancer. If the European Commission grants marketing authorisation, individual countries will still need to determine pricing, reimbursement and how the medicine is made available through their healthcare systems.
Explore the EU guides
- EU medicines hub and country directory
- Using an EU prescription in another country
- Buying medicines online in the EU
- How to verify an EU online pharmacy
- Cross-border ePrescriptions and MyHealth@EU
Official sources / References
- Your Europe: prescription expenses and reimbursement — Cross-border prescriptions and EHIC
- Your Europe: presenting a prescription in another EU country — Prescription information and national dispensing rules
- CNS Luxembourg: medicines and medical devices — Positive list and exceptional authorisation
- Kanta: purchasing prescription medicines abroad — Use of Finnish e-prescriptions in Europe; reimbursement
- European Commission: cross-border healthcare overview — National Contact Points
- EOPYY: official EU/EEA National Contact Point directory — Country contact listings; updated 20 August 2026
MediSearcher explains access routes and official information. Treatment choices belong with your prescriber and pharmacist. About MediSearcher.